# Fresenius Kabi USA LLC - Inspection Records

Source: https://www.keypedia.com/companies/fresenius-kabi-usa-llc/f694c817-29ea-47cf-b819-8cf11fbfc4da

> Inspection records and compliance data for Fresenius Kabi USA LLC in Melrose Park, Illinois. Access full analysis and detailed observations.

---

## Details

- Name: Fresenius Kabi USA LLC
- FEI Number: 1450022
- City: Melrose Park
- State: Illinois
- Country Name: United States
- Address Line 1: 2020 N Ruby St
- Zip Code: 60160
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1311592 - Fresenius Kabi USA LLC - 2026-02-18](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/b6239358-2649-472f-8836-ed0aeaeebc15) — source: FDA, date: February 18, 2026
- [483 - Fresenius Kabi USA LLC - 2023-08-24](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/183d3035-6c45-45d2-9875-3c4a6db4457e) — source: FDA, date: August 24, 2023
- [FDA Inspection 1216183 - Fresenius Kabi USA LLC - 2023-08-24](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/36556a19-8f7e-4700-8789-57d67d5eb31b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2023
- [483 - Fresenius Kabi USA LLC - 2022-06-30](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/f85aed16-5fb4-4bea-9af4-d3c50dfa74b0) — source: FDA, date: June 30, 2022
- [FDA Inspection 1174894 - Fresenius Kabi USA LLC - 2022-06-30](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/840588fe-a12c-4d6a-9e65-ebef63b1314e) — classification: Official Action Indicated (OAI), source: FDA, date: June 30, 2022
- [483 - Fresenius Kabi USA LLC - 2020-05-18](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/c5c70f4e-1342-4dae-8ea8-fdfc56c82c6f) — source: FDA, date: May 18, 2020
- [483 - Fresenius Kabi USA LLC - 2020-05-18](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/d336177f-cc20-4bc6-a876-9138e3d07f5a) — source: FDA, date: May 18, 2020
- [FDA Inspection 1123748 - Fresenius Kabi USA LLC - 2020-05-18](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/4e8339bd-5f21-40a2-acce-2180fef0a96e) — classification: Official Action Indicated (OAI), source: FDA, date: May 18, 2020
- [FDA Inspection 1075139 - Fresenius Kabi USA LLC - 2018-12-03](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/abf5e919-aaf6-442e-9c1a-86d1ab0fb459) — classification: No Action Indicated (NAI), source: FDA, date: December 3, 2018
- [FDA Inspection 1075139 - Fresenius Kabi USA LLC - 2018-12-03](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/27696f80-6af5-4fcb-ac6d-5082a01f64a6) — classification: No Action Indicated (NAI), source: FDA, date: December 3, 2018
- [FDA Inspection 943126 - Fresenius Kabi USA LLC - 2015-09-18](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/1581c788-44f7-44e0-a7f7-1c6f4a746bee) — classification: No Action Indicated (NAI), source: FDA, date: September 18, 2015
- [483 - Fresenius Kabi USA LLC - 2015-09-01](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/bf293339-7005-45af-931f-376032c0316d) — source: FDA, date: September 1, 2015
- [FDA Inspection 943391 - Fresenius Kabi USA LLC - 2015-09-01](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/e4ffee97-c142-4800-bbeb-2dc208cc20c0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 1, 2015
- [483 - Fresenius Kabi USA LLC - 2013-12-11](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/74b1c598-2a46-48fa-900b-2a48f0906013) — source: FDA, date: December 11, 2013
- [FDA Inspection 855192 - Fresenius Kabi USA LLC - 2013-12-11](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/bb21e2c7-0de4-46d2-a1fe-6e554b1bbff7) — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2013
- [FDA Inspection 855192 - Fresenius Kabi USA LLC - 2013-12-11](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/b8a68061-207f-454d-97ee-802604d5eb62) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2013

## Related Companies

- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg/6b51041e-37a7-4672-a7e2-c3c871d6231b)
- [Seqirus Pty Ltd](https://www.keypedia.com/companies/seqirus-pty-ltd/673f8bd1-d8ea-4125-a3cf-a83827b17359)
- [Tairgi Tread-Lia Baile Na Sceilge Teoranta (Ballinskelligs Veterinary Products)](https://www.keypedia.com/companies/tairgi-tread-lia-baile-na-sceilge-teoranta-ballinskelligs-veterinary-products/dbd09df1-6325-40f1-8c46-c4f2c4cb9bc3)
- [Agnitio Inc](https://www.keypedia.com/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb)
- [Amneal Complex Products Research LLC](https://www.keypedia.com/companies/amneal-complex-products-research-llc/a2be8996-ba6b-481d-b935-b75129500758)
- [LFB USA, Inc.](https://www.keypedia.com/companies/lfb-usa-inc/0ce33194-ad37-4a33-ac26-fb8a40ba3c7c)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/d29a124f-fdcb-4108-9eac-661149b4d20e)
- [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/9bedb5d4-0483-4173-bc76-1c5737a28fc1)
- [Iso-Tex Diagnostics, Inc.](https://www.keypedia.com/companies/iso-tex-diagnostics-inc/59c59676-32cc-4749-b95d-3bdc31559b58)
- [Aurobindo Pharma Ltd](https://www.keypedia.com/companies/aurobindo-pharma-ltd/169fdedf-28b5-446b-84f4-65ca9bc54a1a)

## Related Officers

- [Investigator](https://www.keypedia.com/people/russell-k-riley/4813d9c2-52a3-4eba-8606-d4be5e03fd04)
- [investigator](https://www.keypedia.com/people/john-m-seale/70f61741-8e1d-4345-af38-19a2f5360536)
- [Compliance Officer at FDA](https://www.keypedia.com/people/christopher-d-leach/2a3c4b73-f082-4f33-aa2d-52d1abbb6d55)
- [Brian D. Nicholson](https://www.keypedia.com/people/brian-d-nicholson/83ea13dd-6753-468a-a0ca-19e3ef4158dd)
- [Michele L. Glendenning](https://www.keypedia.com/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)
